Continuous Glucose Monitoring (CGM) Device Market Size, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Clinical Trial Trends, Market Share, and Demand Forecast

Revenue, 2025

USD 5.74 Bn

Forecast Year, 2035

USD 11.23 Bn

CAGR, 2026 - 2035

6.94%

Report Coverage

Global

What is the Continuous Glucose Monitoring (CGM) Device Market Size?

The continuous glucose monitoring device market size accounted for USD 5.74 billion in 2025 and is predicted to increase from USD 6.16 billion in 2026 to approximately USD 11.23 billion by 2035, representing a CAGR of 6.94% from 2026 to 2035. The rising prevalence of diabetes, advances in medical device technologies, and the growing demand for early diagnosis drive the market.

Market Highlights

• North America dominated the market with share of 39% in 2025.
• By component, the sensors segment dominated the market in 2025.
• By component, the integrated insulin pumps segment is expected to witness the fastest growth during the forecast period.
• By end user, the home healthcare segment held the largest market share in 2025.
• By end user, the hospitals segment is projected to grow at the fastest CAGR over the forecast period.
• By demographics, the adult population segment accounted for the largest market share in 2025.
• By demographics, the child population (≤14 years) segment is expected to expand at the fastest CAGR during the forecast period.

Market Overview

The market for CGM devices is rapidly growing due to increasing emphasis placed by the healthcare system on the need for managing diabetes, the use of CGM devices allows one to receive information about blood sugar levels in real time, which makes their application more beneficial compared to other testing methods, such as testing using finger-prick.

Technology is significantly contributing to the development of markets, contemporary CGM devices have better sensor precision, higher durability periods, mobile phone connectivity, data sharing through cloud services, and artificial intelligence capabilities, such features improve patient convenience and enable tailored therapy choices, the growing number of integrations with digital healthcare platforms and remote patient monitoring solutions is reinforcing the importance of CGM technology for diabetes management.

Apart from that, the industry has been positively impacted by the increasing prevalence of diabetes around the world, higher spending on health care, and increased availability top sophisticated monitoring devices, there has been a rising demand for CGM their prices in emerging countries, especially in the Asia- Pacific region owing to better infrastructure and awareness of the benefits of CGM, the CGM market has seen and will continue to see healthy growth in the coming years.

AI in the Market

AI is doing wonders in the CGM device market by boosting accuracy, personalization, and predicting abilities. artificial intelligence algorithms are being used to analyze glucose data for pattern detection, fluctuation forecasting, and timely alerts for hypoglycemic events, among others. Thus, the healthcare professionals as well as the users get the chance to make dietary, activity, or medication-related adjustments proactively. Besides, AI contributes to sensor calibration and decreases measurement errors by getting through the user's specific physical responses. It also enables monitoring from a distance, and it helps in optimizing the device. Data interpretation is done by AI, and user engagement is improved through tailored recommendations and virtual coaching.

Continuous Glucose Monitoring (CGM) Device Market Growth Factors

• Diabetes occurrence has been rapidly growing worldwide, thereby driving the continuous glucose monitoring devices market with the cloud: the more the number of individuals who need effective alternatives to managing glucose aggregates, the more the demand for CGM devices.
• The older population aged 65 years and above, much prone to diabetes and hyperglycemic conditions, drives the demand for continuous glucose monitoring devices globally.
• Greater awareness about diabetes management, increased disposable income, and increased government health expenditure all operate as supporting factors towards CGM technology adoption.
• Unhealthy eating habits lead to overweight and burning to obesity levels among people, both significant contributors to diabetes, an increasingly privileged stage for demand for state-of-the-art continuous glucose monitoring support.
• The CGM was highly appreciated and matured into a new program through the CGM technologies, which coupled sensors with wireless connectivity in providing cutting-edge support.
• The increasing frequency of diabetes patients prompts the adoption of CGM devices.
• The aging population's vulnerability to hyperglycemia necessitates precise monitoring.
• The market for advanced glucose monitoring technologies is supported by rising awareness and disposable incomes.
• The wireless connectivity and real-time tracking are some technological advancements that have made CGM devices more accessible.
• The focus on obesity and lifestyle-related disorders continues to strengthen the market outlook.

Market Outlook

• Industry Growth Overview: The continuous glucose monitoring (CGM) device market is experiencing robust growth, driven by the increasing prevalence of diabetes, the availability of needle-free devices, and the growing demand for point-of-care (PoC) diagnostics.
• Global Expansion: Key players collaborate to deliver their proprietary products across diverse geographical locations and file regulatory approvals for that particular region. This enables them to serve a larger patient population and strengthen their position in the market.
• Startup Ecosystem: The startup ecosystem is maturing, driven by the growing demand for non-invasive, needle-free devices, the rising adoption of smart technologies, and advancements in long-term implantable sensors. Afsos Technologies, Signos, Senseonics, and Ultrahuman are major startups involved in CGM device development.

Market Scope

Market Dynamics

Drivers

Rising Diabetes Prevalence

The increasing global prevalence of diabetes-Because it is an aging population, has led to obesity and sedentary lifestyles an apt drivers for propagating and proliferating the CGM market. As diabetes patients increases, especially those suffering from type 2 diabetes and in need of management, the installation of glucose management tools has increased. Continuous glucose monitoring devices provide 24 h monitoring with real-time data serving as an aid in disease management and prevention of serious complications. The demand for convenient monitoring solutions is fomenting the adoption and subsequent boom of the CGM market in various parts of the world.

Restraint

Limited Accessibility

Access to continuous glucose monitoring technology remains limited in rural and underserved areas, and that stands to be a major roadblock for market growth. Many populations face barriers: poor healthcare infrastructure, lack of specialist care, affordability, and the like. These restrict the availability and use of the CGM devices, and many diabetics go untreated with advanced monitoring solutions. It is an issue that shakes the accessibility landscape of these devices, and focused efforts towards improvements in distribution, healthcare delivery, and education are never cheap and slow down the rapid adoption of CGM technology in certain parts.

Opportunity

Digital Health Integration

There are big opportunities for probable growth in remote health monitoring purposes and treatment through the integration of continuous glucose monitoring (CGM) systems with smartphones, smartwatches, and telemedicine platforms. Because of the presence of such integration, it would basically mean seamless connectivity to enhance a user's experience with real-time monitoring, easy sharing of data, and ultimately, personalized feedback. The end-goal view is that the full-scale remote monitoring of patients helps doctors keep track of their patients' health continuously so that interventions can be made at the right time, leading to better care management. Hence, the integration of digital health promotes patient engagement with their treatment and enables self-care. As digital health technologies progress and get accepted, the integration of these technologies with CGM devices will be porous and penetrate even more into delivering diabetes care in the market.

Segments Insights

Component Insights

Why The Sensors Segment Dominates the Continuous Glucose Monitoring Device Market?

The sensors segment dominated the continuous glucose monitoring device market in 2025, due to the fact that sensors are the most vital components of the product line as it is they that measure the levels of glucose continuously, they need for periodic replacement of sensors keeps up the demands and revenues on account of which they become the major revenues in generators.

Integrated Insulin Pumps segment expects the fastest growth in the market during the forecast period, due to the growing use of automated insulin delivery systems, the automated insulin delivery systems involve monitoring of glucose levels and administrating of insulin in a convenient manner, factors such as increasing personalised care requirements, technical innovations, and increased demand for connected diabetes solutions will drive the segment's growth.

End User Insights

Why the Home Healthcare Segment Dominates the Continuous Glucose Monitoring Device Market?

The home healthcare segment dominated the continuous glucose monitoring device market in 2025, because of the rise in popularity of convenient and self- managed diabetes treatment, the CGM devices allow users to track their blood sugar levels continuously and avoid the necessity of regular trips two hospitals for treatment, the rising awareness about home health care, adoption of wearables, and the necessity of continuous tracking contribute to the dominance of this segment in the market.

Hospitals segment expects the fastest growth in the market during the forecast period, due to the increasing use of advanced monitoring equipment to manage diabetes at hospitals, hospitals are utilizing CGM technology to control blood sugar level and get effective results, in addition, the increasing inclination towards diabetes hospitalization and a digital healthcare is adding to the growth of the hospitals segment.

Demographics Insights

Why the Adult Population Segment Dominates the Continuous Glucose Monitoring Device Market?

The adult population segment dominated the continuous glucose monitoring device market in 2025, due to the higher occurrence of diabetes amongst adults as compared to other segments, the growth in demand for CGM can be attributed to the increased awareness regarding the management of disease, increasing usage of wearable technology, for continuous glucose monitoring, furthermore, lifestyle changes and higher occurrence of type 1 and type 2 diabetes also play an important role.

Child Population (≤14 years) segment expects the fastest growth in the market during the forecast period, because the CGM market on account of the growing prevalence of type 1 diabetes among teenagers, greater awareness among the parents and the medical fraternity, increased availability of sophisticated technology along with higher acceptance of variables has been contributing to segment growth.

Regional Insights

Why North America is Dominating the Continuous Glucose Monitoring Device Market?

North America Dominate Continuous Glucose Monitoring Device Market, because it is the region that is holding the largest venue share globally, market growth is enabled by the high number of diabetic cases, superior healthcare facilities, remunerative reimbursement systems, and digitalization in the region, the availability of leading companies with CGM devices, rising awareness about diabetes, and technological advancements also play an important role in the market development.

Early detection assists in identifying and prescribing medication for rare diseases, and CGM devices significantly improve the prevention of diseases, as they provide real-time tracking of blood sugar levels and continuously measure glucose levels in the interstitial fluid. In addition, Canada also plays a crucial role as it provides patients with government initiatives and promotes awareness regarding the advantages of glucose monitoring.

U.S. Continuous Glucose Monitoring (CGM) Device Market Size 2026 To 2035

The U.S. continuous glucose monitoring device market was valued at USD 1.57 billion in 2025 and is projected to grow around USD 3.10 billion by 2035, growing at a CAGR of 7.04% between 2026 and 2035.

U.S. Continuous Glucose Monitoring Device Market Trends

Due to the large base of diabetics present in the country along with high expenditure on health care and quick adoption of medical technology advancements, positive insurance coverage, rising remote patient monitoring trends, and high demand for wearable devices will keep fuelling market growth, innovation among top CGM device manufacturers and rising awareness of managing diabetes will further aid market growth in the coming years.

• In May 2025, Roche announced a $550 M investment to expand its continuous glucose monitoring systems manufacturing hub in the United States. The project aims to provide innovative monitoring solutions for diabetes.

Asia Pacific Continuous Glucose Monitoring Device Market Trends

Asia Pacific expects the fastest growth in the market during the forecast period, because of high incidences of diabetes, development of healthcare infrastructure, and increased awareness about glucose monitoring devices, increased spending on health care, easy availability of medical devices, and increased use of technology in the region in countries like China, India and Japan are boosting the growth of the market.

China Continuous Glucose Monitoring Device Market Trends

Due to the presence of large diabetic population and emphasis on preventive health care in the region, increased spending on health care, availability off more advanced medical technology, and awareness about continuous glucose monitoring will fuel the demand for CGM, the government measures to increase the chronic diseases management capability of the healthcare system, along with the use of digital and wearable technology in healthcare, will boost the market growth potential.

• According to Volza's India Export data, China exported 5402 shipments of Glucose monitoring.

India Continuous Glucose Monitoring (CGM) Device Market Trends

India is significantly growing in the continuous glucose monitoring market. The growing adult diabetes population in the nation increases demand for CGM devices. The high prevalence of diabetes 2 helps in the market growth. The growing awareness about the advantages of CGM devices increases the adoption of CGM devices. The growing prevalence of diabetes and the rising trend of preventive healthcare fuel demand for CGM devices. The aging population and the growing diabetes in older people drive the overall growth of the market.

• For instance, according to the International Diabetes Federation, in 2024 number of adults (20-79) suffering from diabetes was 89.8 million.

What are the Advancements in the Continuous Glucose Monitoring Device Market in Europe?

Europe is expected to have significant market growth during the forecast period, driven by a combination of an aging population, increasing diabetes prevalence, and the growing adoption of advanced monitoring technologies. The European market is also being supported by healthcare policies that promote diabetes care and management. Countries like Germany, the UK, and France are leading players in the region.

Germany Market Trends

Collaborations between technology firms and healthcare providers are becoming increasingly common in the region, which helps in fostering a fertile environment for innovation. Moreover, European regulatory standards emphasize patient safety and quality control, further encourage the adoption of high-performance continuous glucose monitoring devices.

What are the Key Trends in the Blood Glucose Monitoring Market in Latin America?

Latin America is expected to witness significant amount of growth in the market, fueled by improvements in healthcare access, increasing awareness of diabetes management, and rising investments in healthcare infrastructure. Although affordability still remains to be a challenge, efforts to improve access to glucose monitoring solutions in public healthcare systems are supporting market growth. Countries such as Brazil and Mexico are leading players.

Brazil Market Trends

The country's vast population, coupled with a rising incidence of diabetes, helps to create substantial market demand. The rising prevalence of diabetes and a heightened focus on preventive healthcare are key drivers propelling market expansion. Technological advancements are also helping in enhancing the accuracy and reliability of continuous glucose monitoring devices.

South America Expects the Significant Growth in the Market

Because of the rise in the prevalence of diabetes cases, better access to health care, and increased awareness of glucose monitoring technology, growth in investments made towards healthcare, increased use of wearable medical devices, and efforts to improve chronic disease management have been promoting growth in this market.

Brazil Continuous Glucose Monitoring Device Market Trends

Due to the prevalence of diabetes patient in Brazil and improved healthcare infrastructure, increasing awareness regarding the management of diabetes, higher use of wearable technology in healthcare applications, and the increasing availability of monitoring devices are factors that will boost the growth of this market, efforts from the government to improve chronic disease care and investments in health care will help increase market demand.

Regulatory Landscape of the Continuous Glucose Monitoring (CGM) Device Market

Value Chain Analysis

• Raw Material and Component Sourcing: Raw material sourcing focusses on biosensor components, electronic parts and medical grade consumers. Core materials include enzymes, glucose, mediator chemicals, conductive inks and electrode materials.
  Key Players: Roche, Merck, DuPont
• Manufacturing Process: This stage involves biosensor fabrication, test strip coating, cutting, meter assembly and sensor integration. High volume precision manufacturing is required here to ensure accuracy and consistency.
  Key Players: Abbott, Roche, Dexcom
• Distribution Process: The distribution process is carried out through hospitals, clinics, pharmacies, diabetic care centers and e-commerce platforms. Purchasing decisions focus on brand reliability, accuracy, ease of use, cost and digital integration.
  Key Players: CVS Health, Cardinal, Amazon

Competitive Analysis

The CGM device market is very competitive, with companies emphasising innovation, accuracy, connectivity, and patient convenience, play leading companies, such as Abbott Laboratories, Dexcom, and Medtronic, have established themselves in the market owing to their comprehensive product portfolio and wide distribution channels, there is a heavy investment being made by the companies towards developing advanced sensors, artificial intelligence analytics, smartphone technology, and OTC products to enhance their presence in the market, the upcoming firms like senseonics holdings have also entered the market with advanced products.

Merger & Acquisition Trends in the Continuous Glucose Monitoring (CGM) Device Market

• In July 2026, Cardinal Health announced the acquisition of the diabetes business of AdaptHealth and all businesses of Strive Medical, a specializer of urology supplies, for about $360 million in cash. (Source: https://www.hmenews.com)
• In July 2026, Glucotrack completed a strategic business combination with Lōkahi Therapeutics to integrate Lōkahi's dual-engine model of late-stage clinical development capabilities and ai2platform-driven asset sourcing with Glucotrack's existing technology infrastructure. (Source: https://www.drugdeliverybusiness.com)
• In July 2025, OSR Holdings acquired South Korean Woori IO, developer of non-invasive CGM devices. WORIO's CGM completed a proof-of-concept study in Korea, earning approvals to conduct a large confirmatory trial to validate its accuracy and effectiveness. (Source: https://www.mddionline.com)

Continuous Glucose Monitoring (CGM) Device Market Companies

• Abbott Laboratories
• Dexcom, Inc.
• A. Menarini Diagnostics
• Echo Therapeutics, Inc.
• GlySens Incorporated
• Johnson & Johnson
• Medtronic plc
• Senseonics Holdings, Inc.
• F. Hoffmann-La Roche Ltd
• Ypsomed

Key Companies & Market Share Insights

The market is moderately fragmented with the presence of several local companies. These market players are striving to gain higher market share by adopting strategies, such as investments, partnerships, and acquisitions & mergers. Companies are also spending on the development of improved products. Moreover, they are also focusing on maintaining competitive pricing.

• In February 2020, Abbott and Insulet entered into a partnership to develop CGM device by integrating automatic insulin deliver and glucose sensing technologies that can provide enhanced CGM solutions.
• In November 2020, Medtronic acquire FDA approval for InPen, a smart insulin pen that can serve those diabetic patients who are on daily insulin injections.

The various developmental strategies like mergers, acquisitions, and partnerships foster market growth and offers lucrative growth opportunities to the market players.

Recent Developments

• In June 2026, FiberSense AG announced that it received CE marking for its FiberSense Continuous Glucose Monitoring (CGM) system as a Class IIb medical device. The advanced optical sensing technology measures glucose concentrations in the tissue fluid beneath the skin. (Source: https://www.prnewswire.com)
• In March 2026, Zydus Lifesciences announced the launch of its Diasens and GlucoLive, next-generation CGM devices. These devices leverage AI-powered insights and integrated remote care capabilities to monitor glucose and enable a closed-loop care ecosystem connecting patients, caregivers, and clinicians in real time. (Source: https://www.expresspharma.in)
• In June 2025, Tracky, a Thane-based healthtech startup, launched India's first Bluetooth-enabled Continuous Glucose Monitor (CGM), aiming to revolutionize diabetes care and preventive health management. (Source: https://www.biospectrumindia.com/)
• In April 2025, Ambrosia, a global leader in real-time health monitoring, has launched India's first 24x7 glucose and stress monitoring service, integrating wearable sensor technology, AI, and remote monitoring. (Source: https://www.business-standard.com)
• Roche: In September 2024, Roche launched its first continuous glucose monitor (CGM), authorized for Type 1 or Type 2 diabetes.
• Eversense: In October 2024, Eversense launched the 365 CGM system, which is specifically designed to reduce device frustrations
• Abbott: In September 2024, Abbot announced its new launch, Lingo, its continuous glucose monitoring (CGM) technology.

Segments Covered in the Report

By Component

• Transmitters
• Receivers
• Sensors
• Integrated Insulin Pumps

By End User

• Hospitals
• Home Healthcare
• Others

By Demographics

• Child Population (≤14 years)
• Adult Population (>14 years)

By Region

• North America
  
• Latin America
  
• Europe
  
• Asia-pacific
  
• Middle and East Africa